AI-Enabled Metabolite Marker Discovery for Authentication and Quality Control of Herbal Medicines

Authors

  • Anlong Lin School of Information Technology, University of Cincinnati, Cincinnati, OH, USA. Author
  • Bjorn Park Department of Computer Science, University of Central Florida, Orlando, FL, USA. Author
  • Mason R. Oliver Department of Computer Science, University of Houston, Houston, TX, USA. Author

Keywords:

artificial intelligence; metabolomics; herbal medicine authentication; quality control; data infrastructure; regulatory governance

Abstract

The authentication and quality control of herbal medicines present persistent analytical and regulatory challenges because herbal materials exhibit complex chemical profiles, taxonomic ambiguity, and substantial variation arising from geographic origin, cultivation practice, harvest timing, and post-harvest processing. Metabolomics has emerged as a powerful strategy for capturing this chemical complexity, yet the transformation of high-dimensional spectral data into reliable, operationally usable marker panels remains difficult. Artificial intelligence offers considerable promise for metabolite marker discovery by learning latent patterns from large analytical datasets, but its deployment in herbal medicine quality systems requires attention to far more than predictive accuracy. This paper examines the system-level architecture of AI-enabled marker discovery, emphasizing data infrastructure, standardization, modeling trade-offs, interpretability, integration into authentication workflows, robustness, fairness, governance, and sustainable deployment. It argues that AI-based marker discovery should be understood as a socio-technical infrastructure rather than as an isolated computational exercise. The discussion connects analytical chemistry, machine learning, regulatory science, and supply chain governance to identify structural conditions under which AI can produce defensible and durable markers for herbal authentication. Particular attention is given to the need for metadata completeness, transparent model explanations, staged validation across biological and operational variability, and alignment with international regulatory expectations. The paper concludes by outlining forward-looking strategies for federated data governance, lightweight model deployment, and continuous post-market surveillance in distributed herbal supply chains.

References

1. Fiehn, O. (2002). Metabolomics—the link between genotypes and phenotypes. Plant Molecular Biology, 48(1–2), 155–171.

2. Gika, H. G., Theodoridis, G. A., Plumb, R. S., & Wilson, I. D. (2014). Current practice of liquid chromatography–mass spectrometry in metabolomics and metabonomics. Journal of Pharmaceutical and Biomedical Analysis, 87, 12–25.

3. da Silva, R. R., Dorrestein, P. C., & Quinn, R. A. (2015). Illuminating the dark matter in metabolomics. Proceedings of the National Academy of Sciences, 112(41), 12549–12550.

4. Hastings, J., Owen, G., Dekker, A., Ennis, M., Kale, N., Muthukrishnan, V., Turner, S., & Steinbeck, C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Research, 44(D1), D1214–D1219.

5. Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W.-M., Fiehn, O., Goodacre, R., Griffin, J. L., Hankemeier, T., Hardy, N., Harnly, J., Higashi, R., Kopka, J., Lane, A. N., Lindon, J. C., Marriott, P., Nicholls, A. W., ... Viant, M. R. (2007). Proposed minimum reporting standards for chemical analysis. Metabolomics, 3(3), 211–221.

6. Goodacre, R., Broadhurst, D., Smilde, A. K., Kristal, B. S., Baker, J. D., Beger, R., Bessant, C., Connor, S., Capuani, G., Craig, A., Ebbels, T., Kell, D. B., Manetti, C., Newton, J., Paternostro, G., Somorjai, R., Sjöström, M., Trygg, J., & Wulfert, F. (2007). Proposed minimum reporting standards for data analysis in metabolomics. Metabolomics, 3(3), 231–241.

7. Pang, Z., Chong, J., Zhou, G., de Lima Morais, D. A., Chang, L., Barrette, M., Gauthier, C., Jacques, P.-É., Li, S., & Xia, J. (2021). MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Research, 49(W1), W388–W396.

8. LeCun, Y., Bengio, Y., & Hinton, G. (2015). Deep learning. Nature, 521(7553), 436–444.

9. Topol, E. J. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56.

10. Rajkomar, A., Dean, J., & Kohane, I. (2019). Machine learning in medicine. New England Journal of Medicine, 380(14), 1347–1358.

11. Breiman, L. (2001). Random forests. Machine Learning, 45(1), 5–32.

12. Lundberg, S. M., & Lee, S.-I. (2017). A unified approach to interpreting model predictions. In Advances in Neural Information Processing Systems 30 (pp. 4765–4774). Curran Associates.

13. Ribeiro, M. T., Singh, S., & Guestrin, C. (2016). Why should I trust you? Explaining the predictions of any classifier. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (pp. 1135–1144). ACM.

14. World Health Organization. (2007). WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. World Health Organization.

15. European Medicines Agency. (2011). Guideline on quality of herbal medicinal products/traditional herbal medicinal products (EMA/HMPC/201116/2005 Rev. 2). European Medicines Agency.

16. Food and Drug Administration. (2016). Botanical drug development: Guidance for industry. U.S. Department of Health and Human Services.

17. Guidotti, R., Monreale, A., Ruggieri, S., Turini, F., Giannotti, F., & Pedreschi, D. (2018). A survey of methods for explaining black box models. ACM Computing Surveys, 51(5), 1–42.

18. Zhao, K., Li, G., Li, C., Jiang, T., Wang, W., & Yang, Z. (2026). Identification Markers for Salvia miltiorrhiza and Its Close Relatives Based on Cell Wall Component Characteristics. Engineered Science, 40, 2122.

19. Wishart, D. S. (2016). Emerging applications of metabolomics in drug discovery and precision medicine. Nature Reviews Drug Discovery, 15(7), 473–484.

20. Nicholson, J. K., & Lindon, J. C. (2008). Systems biology: Metabonomics. Nature, 455(7216), 1054–1056.

21. Li, S., Han, Q., Qiao, C., Song, J., Cheng, C. L., & Xu, H. (2008). Chemical markers for the quality control of herbal medicines: an overview. Chinese Medicine, 3, 7.

Downloads

Published

2026-07-11